List of authors. Paul A. Offit, M.D New England Journal of Medicine January 23, 2023 in Wuhan, China. Two months later, the original strain of SARS-CoV-2, called the Wuhan-1 or ancestral strain, was isolated and sequenced. It was now possible to make a vaccine. All the vaccines, including the mRNA vaccines made by Pfizer–BioNTech and […]
Authors: Authored by Professor Josh Guetzkow via Jackanapes Junction January 9, 2023 INTRODUCTION Finally! Zachary Stieber at the Epoch Times managed to get the CDC to release the results of its VAERS safety signal monitoring for COVID-19 vaccines, and they paint a very alarming picture (see his reporting and the data files here, or if that is behind […]
Authors: The Journal of Heart and Lung Transplant November 18. 2022 Purpose: Anti-severe acute respiratory syndrome corona virus 2 (SARS- CoV-2) vaccination is recommended by AST, ISHLT, and CDC in all transplant recipients. Lung transplant recipients (LTR) are at a higher risk of developing severe symptoms due to higher immunosuppression (IS) an baseline compromised graft […]
by Abigail Adcox, Healthcare Reporter October 25, 2022 Washington Examiner who had received three shots with the original formula and a fourth shot of Moderna’s or Pfizer-BioNTech’s omicron booster compared to 19 people who had received four shots targeting the original strain. The study suggests that the omicron booster may not protect people from getting infected with the […]
Allowing zealots to censor news in the name of ‘science’ is a danger to public health Authrs: ALEX GUTENTAG CTOBER 18, 2022 Tablet Science In late 2021 and early 2022, it was commonplace for journalists and public intellectuals to demonize and shame “the unvaccinated,” a group that in the United States was disproportionately low income. The New […]
Authors: Bart Jones August 27, 2022 Newsday Some medical experts on Long Island are disputing a new study that said Paxlovid did not help relieve COVID-19 symptoms in people under 65. Pfizer’s COVID-19 pill appears to provide little or no benefit for younger adults, while still reducing the risk of hospitalization and death for high-risk seniors, […]
Authors: Arielle Dreher Axios September 2, 2022 Paxlovid, once hailed as a “game-changer” for its ability to treat COVID-19 infections at home, is becoming one of the pandemic’s biggest enigmas. The intrigue: There’s growing concern about the link between Pfizer’s antiviral pill and COVID rebound, in which patients test positive or have symptoms days after a […]
Authors: Wire servicesJune 21, 2022 Individuals who received two doses of a COVID-19 vaccine have been linked with negative protection against the disease, scientists say in a study analyzing the Omicron wave in Qatar. The research also finds a previous infection without vaccination offers near 50 percent immunity, Published in the New England Journal of Medicine on June 15, the research examined the […]
An Italian review of COVID studies found that boosters restore vaccine effectiveness against omicron initially, but that protection falls off quickly Authors: NBC News July 8, 2022 COVID booster shots appear to be less than 20% effective against infection with the omicron variant of the virus just a few months after the booster is given, a new […]
Authors: Mimi Nguyen Ly June 16, 2022 The Epoch Times Paxlovid, a Pfizer COVID-19 pill, is seen manufactured in Ascoli, Italy, in this undated photo obtained by Reuters on Nov. 16, 2021. (Pfizer/Handout via Reuters) Pfizer has announced it will stop enrollment in a clinical trial for Paxlovid—its COVID-19 antiviral pill—for standard-risk COVID-19 patients after the latest results suggested […]
